The role and mechanism of salivary exosomes in Kawasaki disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300076770

Enrollment

Unknown

Registered

2023-10-18

Start date

2023-10-23

Completion date

Unknown

Last updated

2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kawasaki disease

Interventions

Acute stage of Kawasaki disease:No

health comparison:No

Eligibility

Sex/Gender

All

Age

0.5 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. Comply with the KD Scientific Declaration made by the American Heart Association in 2017 2. The course of the disease is in the acute stage 3. Complete medical history

Exclusion criteria

Exclusion criteria: Patients with a disease course of more than 10 days who had received gamma globulin and hormone therapy before admission.

Design outcomes

Primary

Measure	Time frame
Exosomal protein species;Exosome size;Exosome morphology;	—

Countries

China

Contacts

Public ContactLiu Yang

The Affiliated Hospital of Qingdao University

dianliuyang@163.com+86 131 6123 0808

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026